ISDA

Entry Detail

PDB ID:

1HFS

Keywords:

Title:

CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-764,004

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

1997-02-13

Release Date:

1998-02-18

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.70 Å

R-Value Free:

0.21

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

C 2 2 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:STROMELYSIN-1
Chain IDs:A
Chain Length:160
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P08254 Pfam ID:PF00413 EC:3.4.24.17

Ligand Molecules

L04

Primary Citation

Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.

Esser, C.K, Bugianesi, R.L, Caldwell, C.G, Chapman, K.T, Durette, P.L, Girotra, N.N, Kopka, I.E, Lanza, T.J, Levorse, D.A, MacCoss, M, Owens, K.A, Ponpipom, M.M, Simeone, J.P, Harrison, R.K, Niedzwiecki, L, Becker, J.W, Marcy, A.I, Axel, M.G, Christen, A.J, McDonnell, J, Moore, V.L, Olszewski, J.M, Saphos, C, Visco, D.M, Shen, F, Colletti, A, Krieter, P.A, Hagmann, W.K, Gooley, P.R, O'Connell, J.F, Marcy, A.I, Cuca, G.C, Axel, M.G, Caldwell, C.G, Hagmann, W.K, Becker, J.W, Becker, J.W, Marcy, A.I, Rokosz, L.L, Axel, M.G, Burbaum, J.J, Fitzgerald, P.M, Cameron, P.M, Esser, C.K, Hagmann, W.K, Hermes, J.D, Springer, J.P, Gooley, P.R, O'Connell, J.F, Marcy, A.I, Cuca, G.C, Salowe, S.P, Bush, B.L, Hermes, J.D, Esser, C.K, Hagmann, W.K, Springer, J.P, Johnson, B.A, Chapman, K.T, Kopka, I.E, Durette, P.L, Esser, C.K, Lanza, T.J, Izquierdo-Martin, M, Niedzwiecki, L, Chang, B, Harrison, R.K, Kuo, D.W, Lin, T.Y, Stein, R.L, Hagmann, W.K, Marcy, A.I, Eiberger, L.L, Harrison, R, Chan, H.K, Hutchinson, N.I, Hagmann, W.K, Cameron, P.M, Boulton, D.A, Hermes, J.D.Show

J.Med.Chem. 40 1026 1040 (1997)

PMID: 9083493 DOI: 10.1021/jm960465t

Abstact

Carboxyalkyl peptides containing a biphenylylethyl group at the P1' position were found to be potent inhibitors of stromelysin-1 (MMP-3) and gelatinase A (MMP-2), in the range of 10-50 nM, but poor inhibitors of collagenase (MMP-1). Combination of a biphenylylethyl moiety at P1', a tert-butyl group at P2', and a methyl group at P3' produced orally bioavailable inhibitors as measured by an in vivo model of MMP-3 degradation of radiolabeled transferrin in the mouse pleural cavity. The X-ray structure of a complex of a P1-biphenyl inhibitor and the catalytic domain of MMP-3 is described. Inhibitors that contained halogenated biphenylylethyl residues at P1' proved to be superior in terms of enzyme potency and oral activity with 2(R)-[2-(4'-fluoro-4-biphenylyl)ethyl]-4(S)-n-butyl-1,5-pentane dioic acid 1-(alpha(S)-tert-butylglycine methylamide) amide (L-758,354, 26) having a Ki of 10 nM against MMP-3 and an ED50 of 11 mg/kg po in the mouse pleural cavity assay. This compound was evaluated in acute (MMP-3 and IL-1 beta injection in the rabbit) and chronic (rat adjuvant-induced arthritis and mouse collagen-induced arthritis) models of cartilage destruction but showed activity only in the MMP-3 injection model (ED50 = 6 mg/kg iv).

Legend

Protein

Chemical

Disease

Primary Citation of related structures